The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant.

Scanlen, M

The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant. [electronic resource] - Vaccine Jan 2002 - 1079-88 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0264-410X

10.1016/s0264-410x(01)00445-5 doi


Adjuvants, Immunologic--pharmacology
African Horse Sickness Virus--immunology
Animals
Capsid--immunology
Capsid Proteins
Horses
Immunization
Saponins--adverse effects
Vaccines, Subunit--immunology
Vaccines, Synthetic--immunology
Viral Vaccines--immunology